The real options approach to valuation - Haskayne School of Business
The real options approach to valuation - Haskayne School of Business
The real options approach to valuation - Haskayne School of Business
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Success s<strong>to</strong>ry: Lipi<strong>to</strong>r from Pfizer • Most prescribed name-‐brand in the US with 3.5 million people taking it every day • Enter the market in 1997 and loss patent protec*on at the end <strong>of</strong> Nov. 2011 with <strong>to</strong>tal sales <strong>of</strong> $81 billion • But (WSJ May 2, 2112), Pfizer's first-‐quarter pr<strong>of</strong>it declined 19% as sales <strong>of</strong> its <strong>to</strong>p product, Lipi<strong>to</strong>r, tumbled 71% in the U.S. amid compe**on from generic copies.
Change language